+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Cachexia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • ID: 4754826
  • Clinical Trials
  • February 2019
  • Region: Global
  • 46 pages
  • VPA Research
1 of 2
The ongoing clinical trial research report- “2019 Cachexia Ongoing Clinical Trials Study” analyzes the current scenario of all active Cachexia trials across the world. The report presents top level analysis of global Cachexia clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Cachexia trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Cachexia clinical trials by
  • Region (Asia Pacific, Europe, Middle East Africa and Americas)
  • Countries
  • Trial Phase
  • Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
  • Type of the trial (Interventional, Observational)
  • Sponsor Type (Companies, Universities, Government Bodies etc)
  • Enrollment across types, sponsor types, geographies, current status and phases
The report also identifies the potential drug candidates under development for treatment of Cachexia on the basis of intervention type ongoing Cachexia trials.

The research work is prepared through extensive and continuous research on Cachexia trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Cachexia patients are identified
  • The report includes panorama of ongoing Cachexia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Cachexia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 2
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Cachexia Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
2.2.1 Ongoing Cachexia Clinical Trials by Region
2.2.2 Average Enrollment of Cachexia Clinical Trials
2.2.3 Companies participating in Ongoing Trials
2.2.4 Drugs under Study for Cachexia Treatment, 2019

3. Region wise Cachexia Clinical Trials
3.1 Asia Pacific Cachexia Clinical Trials by Country
3.2 Europe Cachexia Clinical Trials by Country
3.3 North America Cachexia Clinical Trials by Country
3.4 Middle East and Africa Cachexia Clinical Trials by Country
3.5 South and Central America Cachexia Clinical Trials by Country

4. Cachexia Clinical Trial Trends
4.1 Start Year wise Ongoing Cachexia Clinical Trials
4.2 Phase wise Ongoing Cachexia Clinical Trials
4.3 Trial Status wise Ongoing Cachexia Clinical Trials
4.4 Trial Type wise Ongoing Cachexia Clinical Trials

5. Cachexia Average Enrollment Trends
5.1 Average Enrollment in Cachexia Trials by Year
5.2 Average Enrollment in Cachexia Trials by Phase
5.3 Average Enrollment in Cachexia Trials by Status
5.4 Average Enrollment in Cachexia Trials by Type of Trial

6. Companies Participating in Ongoing Cachexia Clinical Trials
6.1 Ongoing Cachexia Trials by Sponsor Type
6.2 Cachexia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots - Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ongoing Cachexia Trials - Phase 1
7.2 Ongoing Cachexia Trials - Phase 2
7.3 Ongoing Cachexia Trials - Phase 3
7.4 Ongoing Cachexia Trials - Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Cachexia Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Figure 7: North America - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Figure 9: Cachexia Ongoing Clinical Trials by Phase
Figure 10: Cachexia Ongoing Clinical Trials by Trial Status
Figure 11: Cachexia Ongoing Clinical Trials by Type
Figure 12: Cachexia Ongoing Clinical Trials by Sponsor Type
Figure 13: Cachexia Ongoing Clinical Trials by Leading Sponsors
Figure 14: Cachexia Average Enrollment by Phase
Figure 15: Cachexia Average Enrollment by Trial Status
Figure 16: Cachexia Average Enrollment by Type
Figure 17: Cachexia - Average Enrolment by Type of Sponsors
Figure 18: Cachexia - Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Cachexia Ongoing Clinical Trials Snapshot - 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Table 5: Europe - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Table 7: North America - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ongoing Cachexia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Cachexia Average Enrollment by Phase
Table 15: Cachexia Average Enrollment by Trial Status
Table 16: Cachexia Average Enrollment by Type
Table 17: Cachexia - Average Enrolment by Type of Sponsors
Table 18: Cachexia - Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll